🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 1/2, multicenter, randomized, double-blind, placebo-controlled t...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00626704
Treatments Being Tested
This is a dose escalation study in female subjects with relapsed ovarian ca...
Status
Completed
Location
TetraLogic research site
Start Date
2013-11
Trial ID
NCT01940172
Treatments Being Tested
The purpose of this protocol is to allow continued treatment with conatumum...
Status
Completed
Location
Research Site
Start Date
2011-03-03
Trial ID
NCT01327612
Treatments Being Tested
This is a multi-center, phase 1b study of AMG 655 in combination with borte...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00791011
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as conatumumab, can block tumor grow...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01017822
Treatments Being Tested
This is a multi-center, 2-part study of AMG 655, AMG 479 or AMG 655-placebo...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00630552
This is a phase 2, multicenter, randomized, double-blind, double-dummy, pla...
Status
Completed
Location
Research Site
Start Date
2009-03
Trial ID
NCT00813605
This is a multi-center, 2-part phase 1b/2 study of AMG 655 in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2009-01-16
Trial ID
NCT00819169
Part 1 is complete. Part 2 is a multi-center, randomized, double-blind, pla...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00534027
Treatments Being Tested
This is an exploratory phase 1b/2, global, multicenter, single-arm, 2-part ...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00630786
Treatments Being Tested